Pliant Therapeutics, Inc.Pliant Therapeutics, Inc.Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc.

No trades
See on Supercharts

PLRX fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Pliant Therapeutics, Inc. engages in the discovery, development and commercialization of therapies for fibrotic diseases. It offers a product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
PLRX has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company